Bridgeway Capital Management’s TELA Bio TELA Stock Holding History
Bought
Maintained
Sold
Other funds holding TELA
EWM
NCM
SCM
SCM
VCM
DCM
PCM
SCM
Bridgeway Capital Management's TELA Position: Q1 2026 in Review
Bridgeway Capital Management sold out of TELA Bio (TELA) in Q1 2026, closing a stake of 57,500 shares — an estimated $67.8K sold.
Bridgeway Capital Management first reported a position in TELA in Q1 2020 and held it in 22 quarters. The position peaked at $1.4M in Q2 2021. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.
- Bridgeway Capital Management reported no remaining TELA Bio position as of Q1 2026 after selling out during the quarter.
- Bridgeway Capital Management sold 57,500 TELA Bio shares in Q1 2026, an estimated $67.8K.
- Bridgeway Capital Management first reported a position in TELA Bio in Q1 2020 and held it in 22 quarters.
- Bridgeway Capital Management's TELA Bio position peaked at $1.4M in Q2 2021.
- 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.
Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.